Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2014

Open Access 01-12-2014 | Research

Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study

Authors: Katharina Rall, Gabriele Conzelmann, Norbert Schäffeler, Melanie Henes, Diethelm Wallwiener, Matthias Möhrle, Sara Y Brucker

Published in: Reproductive Biology and Endocrinology | Issue 1/2014

Login to get access

Abstract

Background

Acne is a very common skin condition during adolescence and adulthood. Patients with uterovaginal agenesis (Mayer-Rokitansky-Küster-Hauser syndrome, MRKH) treated at the Tübingen University Center for Rare Female Genital Malformations, however, clinically appeared to be less frequently affected by acne. The etiology of MRKH syndrome remains unknown. The only known MRKH-associated mutations are located within the WNT4 gene and lead to an atypical form of MRKH syndrome associated with clinical and biochemical hyperandrogenism. Our study aimed to assess the frequency, severity, and self-evaluation of acne in MRKH patients and to correlate the clinical findings with hormone analyses.

Methods

As part of a cross-sectional longterm follow-up study after laparoscopic assisted creation of a neovagina a questionnaire was sent to 149 MRKH patients aged 16–44 years comprising 26 items concerning prevalence and self-evaluation of acne, and the effects of acne on quality of life. The questionnaire was derived from one used in a former epidemiological study of acne in 4,000 women. Blood for hormone analyses was collected routinely during the clinical visit.

Results

Fully completed, evaluable questionnaires were returned by 69/149 (46%) women. Of these respondents, 42 (60.1%) showed hyperandrogenemia without other clinical signs of virilization but only 17 (24.6%) reported acne (8 (11.6%) had physiological acne and 9 (13.0%) clinical acne) and only 10 (14.5%) reported receiving medical treatment for their acne. Effects of acne on quality of life were minor. Only 4 patients (5.8%) with PCOS were identified, among them one with physiological acne, the other three within the acne-free group.

Conclusions

Although hyperandrogenemia is common, acne is significantly less frequent in women with MRKH than reported in the literature for non-MRKH women, and is seldom treated medically. Patients in this study appeared resistant to acne to some extent, possibly due to the sebaceous glands in the acne regions being less sensitive to androgens compared to the normal population. A WNT4 mutation is unlikely to be the main cause of MRKH syndrome in our hyperandrogenemic patients.
Appendix
Available only for authorised users
Literature
1.
Committee on Adolescent Health Care: Committee opinion: no. 562: mullerian agenesis: diagnosis, management, and treatment. Obstet Gynecol. 2013, 121 (5): 1134-1137. 10.1097/01.AOG.0000429659.93470.ed.CrossRef
2.
3.
Laufer MR: Congenital absence of the vagina: in search of the perfect solution. When, and by what technique, should a vagina be created?. Curr Opin Obstet Gynecol. 2002, 14 (5): 441-444. 10.1097/00001703-200210000-00001.CrossRefPubMed
4.
Folch M, Pigem I, Konje JC: Mullerian agenesis: etiology, diagnosis, and management. Obstet Gynecol Surv. 2000, 55 (10): 644-649. 10.1097/00006254-200010000-00023.CrossRefPubMed
5.
Strissel PL, Oppelt P, Cupisti S, Stiegler E, Beckmann MW, Strick R: Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome). Horm Metab Res. 2009, 41 (5): 408-413. 10.1055/s-0028-1105918.CrossRefPubMed
6.
Carranza-Lira S, Forbin K, Martinez-Chequer JC: Rokitansky syndrome and MURCS association–clinical features and basis for diagnosis. Int J Fertil Womens Med. 1999, 44 (5): 250-255.PubMed
7.
Sultan C, Biason-Lauber A, Philibert P: Mayer-rokitansky-Kuster-Hauser syndrome: recent clinical and genetic findings. Gynecol Endocrinol. 2009, 25 (1): 8-11. 10.1080/09513590802288291.CrossRefPubMed
8.
9.
Philibert P, Biason-Lauber A, Rouzier R, Pienkowski C, Paris F, Konrad D, Schoenle E, Sultan C: Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and mullerian duct abnormalities: a french collaborative study. J Clin Endocrinol Metab. 2008, 93 (3): 895-900. 10.1210/jc.2007-2023.CrossRefPubMed
10.
Philibert P, Biason-Lauber A, Gueorguieva I, Stuckens C, Pienkowski C, Lebon-Labich B, Paris F, Sultan C: Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-rokitansky-Kuster-Hauser syndrome). Fertil Steril. 2011, 95 (8): 2683-2686. 10.1016/j.fertnstert.2011.01.152.CrossRefPubMed
11.
Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ: A WNT4 mutation associated with mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med. 2004, 351 (8): 792-798. 10.1056/NEJMoa040533.CrossRefPubMed
12.
Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ: WNT4 Deficiency–a clinical phenotype distinct from the classic Mayer-rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod. 2007, 22 (1): 224-229.CrossRefPubMed
13.
Brucker SY, Gegusch M, Zubke W, Rall K, Gauwerky JF, Wallwiener D: Neovagina creation in vaginal agenesis: development of a new laparoscopic vecchietti-based procedure and optimized instruments in a prospective comparative interventional study in 101 patients. Fertil Steril. 2008, 90 (5): 1940-1952. 10.1016/j.fertnstert.2007.08.070.CrossRefPubMed
14.
Ghodsi SZ, Orawa H, Zouboulis CC: Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009, 129 (9): 2136-2141. 10.1038/jid.2009.47.CrossRefPubMed
15.
Law MP, Chuh AA, Lee A, Molinari N: Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol. 2010, 35 (1): 16-21. 10.1111/j.1365-2230.2009.03340.x.CrossRefPubMed
16.
Poli F, Dreno B, Verschoore M: An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001, 15 (6): 541-545. 10.1046/j.1468-3083.2001.00357.x.CrossRefPubMed
17.
Goulden V, Stables GI, Cunliffe WJ: Prevalence of facial acne in adults. J Am Acad Dermatol. 1999, 41 (4): 577-580.PubMed
18.
Cunliffe WJ, Gould DJ: Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979, 1 (6171): 1109-1110. 10.1136/bmj.1.6171.1109.PubMedCentralCrossRefPubMed
19.
Nast A, Dréno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, Ganceviciene R, Haedersdal M, Layton A, López-Estebaranz JL, Ochsendorf F, Oprica C, Rosumeck S, Rzany B, Sammain A, Simonart T, Veien NK, Zivković MV, Zouboulis CC, Gollnick H: European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012, 26 (Suppl 1): 1-29.CrossRefPubMed
20.
Archer CB, Cohen SN, Baron SE: Guidance on the diagnosis and clinical management of acne. Clin Exp Dermatol. 2012, 37 (Suppl 1): 1-6.CrossRefPubMed
21.
Zouboulis CC: Acne vulgaris. Rolle der hormone [acne vulgaris. The role of hormones]. Hautarzt. 2010, 61 (2): 107-108. 10.1007/s00105-009-1830-1.CrossRefPubMed
22.
Walton S, Wyatt EH, Cunliffe WJ: Genetic control of sebum excretion and acne–a twin study. Br J Dermatol. 1988, 118 (3): 393-396. 10.1111/j.1365-2133.1988.tb02433.x.CrossRefPubMed
23.
Goulden V, McGeown CH, Cunliffe WJ: The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol. 1999, 141 (2): 297-300. 10.1046/j.1365-2133.1999.02979.x.CrossRefPubMed
24.
Balen A: The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004, 18: 685-706. 10.1016/j.bpobgyn.2004.05.004.CrossRefPubMed
25.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81: 19-25.
26.
Ugur M, Karakaya S, Zorlu G, Arslan S, Gülerman C, Kükner S, Gökmen O: Polycystic ovaries in association with müllerian anomalies. Eur J Obstet Gynecol Reprod Biol. 1995, 62: 57-59. 10.1016/0301-2115(95)02157-3.CrossRefPubMed
27.
Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994, 19 (3): 210-216. 10.1111/j.1365-2230.1994.tb01167.x.CrossRefPubMed
28.
29.
Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998, 83 (9): 3078-3082.PubMed
30.
Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000, 85 (7): 2434-2438.PubMed
31.
Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR: Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004, 89 (2): 453-462. 10.1210/jc.2003-031122.CrossRefPubMed
32.
Huang A, Brennan K, Azziz R: Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril. 2010, 93 (6): 1938-1941. 10.1016/j.fertnstert.2008.12.138.PubMedCentralCrossRefPubMed
33.
Rademaker M, Garioch JJ, Simpson NB: Acne in schoolchildren: no longer a concern for dermatologists. BMJ. 1989, 298 (6682): 1217-1219. 10.1136/bmj.298.6682.1217.PubMedCentralCrossRefPubMed
34.
Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE: The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008, 58 (1): 56-59. 10.1016/j.jaad.2007.06.045.CrossRefPubMed
35.
Jansen T, Grabbe S, Plewig G: Klinische formen der akne [clinical variants of acne]. Hautarzt. 2005, 56 (11): 1018-1026. 10.1007/s00105-005-1031-5.CrossRefPubMed
36.
Jemec GB, Linneberg A, Nielsen NH, Frolund L, Madsen F, Jorgensen T: Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology. 2002, 204 (3): 179-184. 10.1159/000057878.CrossRefPubMed
37.
Rott H: Hormonal contraception in thrombophilic adolescents: risk of thrombosis and recommendations. Hamostaseologie. 2012, 32 (1): 15-21.CrossRefPubMed
38.
Wiegratz I, Thaler CJ: Hormonal contraception–what kind, when, and for whom?. Dtsch Arztebl Int. 2011, 108 (28–29): 495-505. quiz 506PubMedCentralPubMed
39.
Schäfer T, Nienhaus A, Vieluf D, Berger J, Ring J: Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol. 2001, 145 (1): 100-104. 10.1046/j.1365-2133.2001.04290.x.CrossRefPubMed
40.
41.
42.
Grabmeier B, Landthaler M, Hohenleutner S: Menstruationszyklus und haut [the menstrual cycle and the skin]. J Dtsch Dermatol Ges. 2005, 3 (1): 52-63. 10.1046/j.1439-0353.2005.04530.x.CrossRefPubMed
43.
Stoll S, Shalita AR, Webster GF, Kaplan R, Danesh S, Penstein A: The effect of the menstrual cycle on acne. J Am Acad Dermatol. 2001, 45 (6): 957-960. 10.1067/mjd.2001.117382.CrossRefPubMed
44.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY: The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999, 140 (4): 672-676. 10.1046/j.1365-2133.1999.02768.x.CrossRefPubMed
45.
Lasek RJ, Chren MM: Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998, 134 (4): 454-458. 10.1001/archderm.134.4.454.CrossRefPubMed
46.
Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman SN: Acne therapy: a methodologic review. J Am Acad Dermatol. 2002, 47 (2): 231-240. 10.1067/mjd.2002.120912.CrossRefPubMed
47.
Stathakis V, Kilkenny M, Marks R: Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 1997, 38 (3): 115-123. 10.1111/j.1440-0960.1997.tb01126.x.CrossRefPubMed
48.
Lucky AW, Barber BL, Girman CJ, Williams J, Ratterman J, Waldstreicher J: A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol. 1996, 35 (4): 559-565. 10.1016/S0190-9622(96)90680-5.CrossRefPubMed
49.
Hayashi N, Akamatsu H, Kawashima M: Establishment of grading criteria for acne severity. J Dermatol. 2008, 35 (5): 255-260.PubMed
50.
Doshi A, Zaheer A, Stiller MJ: A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997, 36 (6): 416-418. 10.1046/j.1365-4362.1997.00099.x.CrossRefPubMed
51.
Burke BM, Cunliffe WJ: The assessment of acne vulgaris–the Leeds technique. Br J Dermatol. 1984, 111 (1): 83-92. 10.1111/j.1365-2133.1984.tb04020.x.CrossRefPubMed
52.
Nast A, Bayerl C, Borelli C, Degitz K, Dirschka T, Erdmann R, Fluhr J, Gieler U, Hartwig R, Meigel E-M, Möller S, Ochsendorf F, Podda M, Rabe T, Rzany B, Sammain A, Schink S, Zouboulis CC, Gollnick H, German Society of Dermatology (DDG) and the Association of German Dermatologists (BVDD): S2k-Leitlinie zur therapie der akne [S2k-guideline for therapy of acne]. J Dtsch Dermatol Ges. 2010, 8: s1-s59.PubMed
Metadata
Title
Acne and PCOS are less frequent in women with Mayer-Rokitansky-Küster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study
Authors
Katharina Rall
Gabriele Conzelmann
Norbert Schäffeler
Melanie Henes
Diethelm Wallwiener
Matthias Möhrle
Sara Y Brucker
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2014
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-12-23

Other articles of this Issue 1/2014

Reproductive Biology and Endocrinology 1/2014 Go to the issue

Research

Expression of leptin and its long form receptor at the porcine maternal-fetal interface: contrasting healthy and arresting conceptus attachment sites during early and mid-pregnancy

Review

In vitro culture of bovine preantral follicles: a review

Research

The term basal plate of the human placenta as a source of functional extravillous trophoblast cells

Research

Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation, fertilization, and embryo quality in humans

Research

Comparison of the biopsy and cytobrush techniques for diagnosis of subclinical endometritis in mares

Research

Relationship amongst teratozoospermia, seminal oxidative stress and male infertility